Universität Wien
Warning! The directory is not yet complete and will be amended until the beginning of the term.

322573 VU Drug Delivery to the Lungs - M7/M14 (2022S)

1.00 ECTS (1.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

Language: English

Lecturers

Classes

Locations will be posted on the Moodle website
Mo - 30.05.2022 - 9:30 -11:30 Uhr - Forschungspräsentation - HS6
Opening Lecture - Prof. Dr. Carsten Ehrhardt, Trinity College Dublin, Galenus Guest Professor

The Biopharmaceutics of ABC Transporters in the Lung

Virtually every cell in the body is equipped with a tightly regulated machinery of membrane transporter proteins. These transporters facilitate cellular entry or efflux of their substrates across lipid bilayer membranes. Efflux transporters, which often require primary or secondary metabolic energy to function, have important physiological roles in maintaining barrier function and cellular detoxification and clearance. In the context of drug delivery, however, the protective function of efflux transporters sometimes negatively impacts on bioavailability, in cases where the drug in question is a substrate for such transporters. This can lead to reduced gastrointestinal absorption, increased hepatic and/or renal clearance and restricted access to certain compartments, such as the CNS. Moreover, upregulated transporter expression in cancer cells can result in resistance of tumours to chemotherapy.

Whilst a wealth of information has been published on transporter effects in drug disposition in the gut, liver, kidneys and the blood-brain-barrier, pulmonary transporter research remains a relatively poorly understood area of research. This presentation will discuss the expression of relevant members ATP-binding cassette (ABC) transporter family, namely, P-glycoprotein (P-gp), multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) in the lung and in addition, will highlight the clinical impact these efflux transporters can have on pulmonary cell physiology, detoxification and drug disposition.
Thur - 02.06.2022 -9:30 -11:30 - Introduction - 2F317
Fri - 03.06.2022 - 9:30 - 11:30 - Lab groups I/II - 2E165
Wed - 08.06.2022 - 9:30- 11:30 - Lab groups III/IV - 2E165
Fri - 10.06.2022 - 9:30-11:30 - Data analysis - 2D404

Fri - 17.06.2022 - Deadline for submission of lab report - MOODLE


Information

Aims, contents and method of the course

Through lectures, seminars and practical experiments, students will learn:
- the latest research developments in pulmonary drug delivery
- perform pharmacopoeial quality control test of inhaler devices

Assessment and permitted materials

Written report of practical results - 75% of the final mark
Multiple choice quiz on the research presentation - 25% of the final mark

Minimum requirements and assessment criteria

A minimum of 50% muss be achieved to pass.

Examination topics

Written practical report: Data generation and analysis of particle size and aerosol properties.

Multiple choice quiz on the research presentation

Reading list


Association in the course directory

A400, MA8, MA23

Last modified: Fr 27.05.2022 12:29